Published in Surgery on July 10, 2008
The identification of stem cells in human liver diseases and hepatocellular carcinoma. Exp Mol Pathol (2010) 0.98
Cultivating hepatocytes on printed arrays of HGF and BMP7 to characterize protective effects of these growth factors during in vitro alcohol injury. Biomaterials (2010) 0.96
Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression. PLoS One (2014) 0.81
Serum thymosin beta4 levels in patients with hepatitis B virus-related liver failure. World J Gastroenterol (2010) 0.80
Local control of hepatic phenotype with growth factor-encoded surfaces. Integr Biol (Camb) (2014) 0.79
Gene therapy for liver regeneration: experimental studies and prospects for clinical trials. World J Gastroenterol (2010) 0.78
Hepatocyte growth factor-modified mesenchymal stem cells improve ischemia/reperfusion-induced acute lung injury in rats. Gene Ther (2016) 0.78
Stimulation of oval cell and hepatocyte proliferation by exogenous bombesin and neurotensin in partially hepatectomized rats. World J Gastrointest Pathophysiol (2011) 0.77
Therapeutic potentials occurring during the early differentiation process of mesenchymal stem cells in a rats model with thioacetamide-induced liver fibrosis. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy. Clin Exp Metastasis (2014) 0.75
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol (2008) 3.27
Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology (2002) 3.16
Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol (2002) 2.61
A novel 3D hepatectomy simulation based on liver circulation: application to liver resection and transplantation. Hepatology (2005) 1.97
Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma. World J Surg (2007) 1.35
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth. J Cell Sci (2004) 1.34
Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology (2005) 1.33
Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer (2003) 1.32
Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut (2006) 1.31
LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis. FEBS Lett (2006) 1.30
Coexpression of Gas6/Axl in human ovarian cancers. Oncology (2004) 1.23
Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis. Am J Physiol Gastrointest Liver Physiol (2007) 1.15
Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse. J Exp Med (2004) 1.12
Management of adrenal metastasis from hepatocellular carcinoma. Surg Today (2002) 1.10
Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation. Nat Med (2008) 1.09
Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings. J Hepatol (2007) 1.06
Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model. Hepatology (2003) 1.04
Phosphorylation of highly conserved neurofilament medium KSP repeats is not required for myelin-dependent radial axonal growth. J Neurosci (2009) 1.04
The impact of 3-D virtual hepatectomy simulation in living-donor liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.00
Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF signalling. Genes Cells (2004) 1.00
Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice. J Hepatol (2009) 0.99
Percutaneous radiofrequency ablation therapy after intrathoracic saline solution infusion for liver tumor in the hepatic dome. J Vasc Interv Radiol (2002) 0.97
Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Hepatology (2013) 0.96
Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer (2009) 0.96
Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice. J Hepatol (2006) 0.95
Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women. Steroids (2003) 0.94
Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers. J Steroid Biochem Mol Biol (2007) 0.94
Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers. J Biomed Sci (2007) 0.93
Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes. Am J Pathol (2005) 0.91
Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int (2002) 0.91
Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats. Am J Pathol (2007) 0.90
Effect of Kupffer cell inactivation on ethanol-induced protein adducts in the liver. Free Radic Biol Med (2002) 0.90
In vivo antitumor activity of Sindbis viral vectors. J Natl Cancer Inst (2002) 0.90
Hemodynamic analysis and treatment of an enlarging extrahepatic portal aneurysm: report of a case. Surg Today (2014) 0.90
Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma. Surg Today (2005) 0.90
New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. J Gastroenterol (2013) 0.89
CT-guided transthoracic percutaneous ethanol injection for hepatocellular carcinoma not detectable with US. Radiology (2002) 0.88
Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model. Am J Physiol Gastrointest Liver Physiol (2004) 0.88
Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20. Pancreas (2009) 0.88
Regulation of cultured rat hepatocyte proliferation by stellate cells. J Hepatol (2002) 0.88
Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway. Lab Invest (2011) 0.87
Role of innate immune response in liver regeneration. J Gastroenterol Hepatol (2007) 0.87
Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci (2010) 0.87
Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. J Rheumatol (2003) 0.87
Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers. Gynecol Oncol (2009) 0.87
TLRs, NF-κB, JNK, and Liver Regeneration. Gastroenterol Res Pract (2010) 0.86
Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Res Ther (2006) 0.86
Laparoscopic management of giant splenic true cyst with partial splenectomy: a case report. Asian J Endosc Surg (2013) 0.86
Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count. Hepatol Res (2013) 0.85
Primary squamous cell carcinoma of the liver: an uncommon finding in contrast-enhanced ultrasonography imaging. Case Rep Gastroenterol (2011) 0.85
Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis. Surg Today (2013) 0.85
The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice. Gastroenterol Res Pract (2010) 0.85
Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation. Blood (2004) 0.85
c-Jun N-terminal kinase activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of retinoic acid receptor α protein in hepatic cells. Cancer Sci (2011) 0.84
Strategy of gene therapy for liver cirrohosis and hepatocellular carcinoma. J Hepatobiliary Pancreat Surg (2003) 0.84
Inactivation of the small GTPase Rac1 protects the liver from ischemia/reperfusion injury in the rat. Surgery (2003) 0.84
Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci (2003) 0.84
Minimally invasive laparoscopic liver resection: 3D MDCT simulation for preoperative planning. J Hepatobiliary Pancreat Surg (2009) 0.84
Angiogenesis is crucial for liver regeneration after partial hepatectomy. Surgery (2012) 0.83
Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene. FEBS Lett (2012) 0.83
Hepatocyte growth factor gene transfer with naked plasmid DNA ameliorates dimethylnitrosamine-induced liver fibrosis in rats. Hepatol Res (2008) 0.83
Adeno-associated virus vector-mediated production of hepatocyte growth factor attenuates liver fibrosis in mice. Hepatol Int (2007) 0.83
Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers. Oncology (2008) 0.82